Results 141 to 150 of about 105,857 (215)

Characteristics of individuals who received a complete, 2-dose mpox vaccine regimen as part of the public health response to the mpox epidemic in Ontario, Canada. [PDF]

open access: yesPLOS Glob Public Health
Grewal R   +12 more
europepmc   +1 more source

First-in-human study of CPL'116 - a dual JAK/ROCK inhibitor - in healthy subjects. [PDF]

open access: yesFront Pharmacol
Rudzki PJ   +12 more
europepmc   +1 more source

Community Mobilization to Guide the Public Health Response During the 2022 Ontario Mpox Outbreak: A Brief Report. [PDF]

open access: yesOpen Forum Infect Dis
Tan DHS   +6 more
europepmc   +1 more source

Editorial: Pathogenomics of the genus Brucella and beyond, volume II. [PDF]

open access: yesFront Microbiol
Cloeckaert A   +4 more
europepmc   +1 more source

Genomic Diversity and Zoonotic Potential of Brucella neotomae. [PDF]

open access: yesEmerg Infect Dis
Vergnaud G   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy